{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T23:58:22Z","timestamp":1787356702398,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009357","name":"Burke Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"New York State Department of Health","doi-asserted-by":"publisher","award":["C023832"],"award-info":[{"award-number":["C023832"]}],"id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.expneurol.2023.114479","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T20:55:44Z","timestamp":1689368144000},"page":"114479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Elevation of NAD+ by nicotinamide riboside spares spinal cord tissue from injury and promotes locomotor recovery"],"prefix":"10.1016","volume":"368","author":[{"given":"Mariajose","family":"Metcalfe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett C.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin E.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2023.114479_bb0005","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.expneurol.2023.114479_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186459","article-title":"An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers","volume":"12","author":"Airhart","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2023.114479_bb0015","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.5552-09.2010","article-title":"NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death","volume":"30","author":"Alano","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0020","author":"Allen Institute for Brain Science"},{"key":"10.1016\/j.expneurol.2023.114479_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3171\/jns.1982.56.1.0106","article-title":"Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment","volume":"56","author":"Anderson","year":"1982","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2023.114479_bb0030","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1098014","article-title":"Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration","volume":"305","author":"Araki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2023.114479_bb0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/089771504323004548","article-title":"Behavioral testing after spinal cord injury: congruities, complexities, and controversies","volume":"21","author":"Basso","year":"2004","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2023.114479_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1995.12.1","article-title":"A sensitive and reliable locomotor rating scale for open field testing in rats","volume":"12","author":"Basso","year":"1995","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2023.114479_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/exnr.1996.0098","article-title":"Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection","volume":"139","author":"Basso","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0050","first-page":"189","article-title":"Descending systems contributing to locomotor recovery after mild or moderate spinal cord injury in rats: experimental evidence and a review of literature","volume":"20","author":"Basso","year":"2002","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/exnr.1997.6695","article-title":"Endogenous repair after spinal cord contusion injuries in the rat","volume":"148","author":"Beattie","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0306-4522(83)90150-1","article-title":"Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling","volume":"10","author":"Blight","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2023.114479_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","article-title":"Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition","volume":"28","author":"Bogan","year":"2008","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.expneurol.2023.114479_bb0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3171\/jns.1984.61.2.0290","article-title":"Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism","volume":"61","author":"Braughler","year":"1984","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2023.114479_bb0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/brain\/awv375","article-title":"Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level","volume":"139","author":"Brommer","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2023.114479_bb0080","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2014.11.003","article-title":"Activation of SIRT3 by the NAD(+) precursor nicotinamide riboside protects from noise-induced hearing loss","volume":"20","author":"Brown","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2023.114479_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40279-022-01772-2","article-title":"NAD(+) therapeutics and skeletal muscle adaptation to exercise in humans","volume":"52","author":"Campelj","year":"2022","journal-title":"Sports Med."},{"key":"10.1016\/j.expneurol.2023.114479_bb0090","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Canto","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2023.114479_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00018-022-04499-5","article-title":"Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations","volume":"79","author":"Cercillieux","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0100","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1523\/JNEUROSCI.3046-16.2017","article-title":"An agonist of the protective factor SIRT1 improves functional recovery and promotes neuronal survival by attenuating inflammation after spinal cord injury","volume":"37","author":"Chen","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cne.20319","article-title":"Differential vulnerability of propriospinal tract neurons to spinal cord contusion injury","volume":"479","author":"Conta","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0960327115626254","article-title":"Safety assessment of nicotinamide riboside, a form of vitamin B3","volume":"35","author":"Conze","year":"2016","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-1-4939-7649-2_28","article-title":"Transplantation of adult rat Schwann cells into the injured spinal cord","volume":"1739","author":"Dai","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0125","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/js.2017-00092","article-title":"Targeting NAD+ in metabolic disease: new insights into an old molecule","volume":"1","author":"Elhassan","year":"2017","journal-title":"J. Endocr. Soc."},{"issue":"1717\u20131728","key":"10.1016\/j.expneurol.2023.114479_bb0130","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD(+) metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep."},{"issue":"421\u2013430","key":"10.1016\/j.expneurol.2023.114479_bb0135","article-title":"TIR domain proteins are an ancient family of NAD(+)-consuming enzymes","volume":"28","author":"Essuman","year":"2018","journal-title":"Curr. Biol."},{"issue":"1118\u20131136","key":"10.1016\/j.expneurol.2023.114479_bb0140","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD(+) ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2023.114479_bb0145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD(+) destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2023.114479_bb0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neuron.2015.12.023","article-title":"Axon self-destruction: new links among SARM1, MAPKs, and NAD+ metabolism","volume":"89","author":"Gerdts","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2023.114479_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molmet.2019.09.013","article-title":"A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor","volume":"30","author":"Giroud-Gerbetant","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.expneurol.2023.114479_bb0165","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer\u2019s mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2023.114479_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113725","article-title":"Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits","volume":"342","author":"Goodus","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/exnr.2001.7628","article-title":"Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion","volume":"168","author":"Grossman","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1602\/neurorx.1.1.80","article-title":"Neuroprotection and acute spinal cord injury: a reappraisal","volume":"1","author":"Hall","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.expneurol.2023.114479_bb0185","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/j.pain.0000000000000862","article-title":"Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats","volume":"158","author":"Hamity","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2023.114479_bb0190","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1074\/jbc.M115.698779","article-title":"Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1)","volume":"291","author":"Harlan","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114479_bb0195","first-page":"1039","article-title":"Disturbances of hydrogen electron transport system and free radical reactions after severe spinal cord injury","volume":"12","author":"Hayashi","year":"1984","journal-title":"No Shinkei Geka"},{"key":"10.1016\/j.expneurol.2023.114479_bb0200","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-021-02337-2","article-title":"Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration","volume":"18","author":"Hellenbrand","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2023.114479_bb0205","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD(+) supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2023.114479_bb0210","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1016\/S0021-9258(18)99829-7","article-title":"Studies on the biosynthesis of nicotinamide adenine dinucleotide. 3. Comparative in vivo studies on nicotinic acid, nicotinamide, and quinolinic acid as precursors of nicotinamide adenine dinucleotide","volume":"241","author":"Ijichi","year":"1966","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114479_bb0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BSD.0000000000000861","article-title":"Neuroprotective agents as an adjuvant treatment in patients with acute spinal cord injuries: a qualitative systematic review of randomized trials","volume":"33","author":"Joaquim","year":"2020","journal-title":"Clin. Spine Surg."},{"key":"10.1016\/j.expneurol.2023.114479_bb0220","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1523\/JNEUROSCI.0696-05.2005","article-title":"Propriospinal circuitry underlying interlimb coordination in mammalian quadrupedal locomotion","volume":"25","author":"Juvin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0225","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/emmm.201403943","article-title":"Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3","volume":"6","author":"Khan","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2023.114479_bb0230","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1007\/s12035-020-02063-5","article-title":"Axonal protection by nicotinamide riboside via SIRT1-autophagy pathway in TNF-induced optic nerve degeneration","volume":"57","author":"Kitaoka","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12974-017-0841-6","article-title":"Interactions between Sirt1 and MAPKs regulate astrocyte activation induced by brain injury in vitro and in vivo","volume":"14","author":"Li","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2023.114479_bb0240","doi-asserted-by":"crossref","first-page":"7207692","DOI":"10.1155\/2021\/7207692","article-title":"Sirtuins: potential therapeutic targets for defense against oxidative stress in spinal cord injury","volume":"2021","author":"Lin","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1067\u20131080","key":"10.1016\/j.expneurol.2023.114479_bb0245","article-title":"Quantitative analysis of NAD synthesis-breakdown fluxes","volume":"27","author":"Liu","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2023.114479_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172520","article-title":"Exogenous nicotinamide adenine dinucleotide administration alleviates ischemia\/reperfusion-induced oxidative injury in isolated rat hearts via Sirt5-SDH-succinate pathway","volume":"858","author":"Liu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0255","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1523\/JNEUROSCI.22-01-00315.2002","article-title":"Functional redundancy of ventral spinal locomotor pathways","volume":"22","author":"Loy","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0260","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/exnr.2002.7959","article-title":"Both dorsal and ventral spinal cord pathways contribute to overground locomotion in the adult rat","volume":"177","author":"Loy","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/exnr.1999.7016","article-title":"Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat","volume":"156","author":"Magnuson","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0270","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3762\/bjoc.15.36","article-title":"Syntheses and chemical properties of beta-nicotinamide riboside and its analogues and derivatives","volume":"15","author":"Makarov","year":"2019","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.expneurol.2023.114479_bb0275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0270(02)00012-2","article-title":"Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination","volume":"115","author":"Metz","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2023.114479_bb0280","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210040","article-title":"Single-cell analysis of the cellular heterogeneity and interactions in the injured mouse spinal cord","volume":"218","author":"Milich","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2023.114479_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113939","article-title":"Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues","volume":"9","author":"Mori","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2023.114479_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147193","article-title":"SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside","volume":"6","author":"Mukherjee","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2023.114479_bb0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1517\/13543784.2015.1009629","article-title":"Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from phase I to II","volume":"24","author":"Nagoshi","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.expneurol.2023.114479_bb0300","doi-asserted-by":"crossref","first-page":"13103","DOI":"10.1038\/ncomms13103","article-title":"NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells","volume":"7","author":"Ratajczak","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2023.114479_bb0305","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.neuroscience.2006.07.017","article-title":"Inter-enlargement pathways in the ventrolateral funiculus of the adult rat spinal cord","volume":"142","author":"Reed","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2023.114479_bb0310","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2009.09.049","article-title":"Anterograde labeling of ventrolateral funiculus pathways with spinal enlargement connections in the adult rat spinal cord","volume":"1302","author":"Reed","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2023.114479_bb0315","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/neu.1997.14.823","article-title":"Quantitative analysis of acute axonal pathology in experimental spinal cord contusion","volume":"14","author":"Rosenberg","year":"1997","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2023.114479_bb0320","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1523\/JNEUROSCI.2320-06.2006","article-title":"Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy","volume":"26","author":"Sasaki","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0325","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1523\/JNEUROSCI.5469-08.2009","article-title":"Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide","volume":"29","author":"Sasaki","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0330","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/neu.2014.3497","article-title":"Spinal cord injury causes chronic liver pathology in rats","volume":"32","author":"Sauerbeck","year":"2015","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2023.114479_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40169-016-0104-7","article-title":"Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders","volume":"5","author":"Srivastava","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.expneurol.2023.114479_bb0340","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pneurobio.2017.10.004","article-title":"And yet it moves: recovery of volitional control after spinal cord injury","volume":"160","author":"Taccola","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2023.114479_bb0345","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2023.114479_bb0350","doi-asserted-by":"crossref","first-page":"26933","DOI":"10.1038\/srep26933","article-title":"Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice","volume":"6","author":"Trammell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2023.114479_bb0355","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1096\/fj.201700221RR","article-title":"Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration","volume":"31","author":"Vaur","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2023.114479_bb0360","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41598-017-00851-z","article-title":"Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2\/HO-1 signaling pathway","volume":"7","author":"Wei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2023.114479_bb0365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/BSD.0000000000000287","article-title":"Acute spinal cord injury","volume":"28","author":"Witiw","year":"2015","journal-title":"J. Spinal Disord. Tech."},{"key":"10.1016\/j.expneurol.2023.114479_bb0370","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/neu.2008.0692","article-title":"Nitric oxide and superoxide anion differentially activate poly(ADP-ribose) polymerase-1 and Bax to induce nuclear translocation of apoptosis-inducing factor and mitochondrial release of cytochrome c after spinal cord injury","volume":"26","author":"Wu","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2023.114479_bb0375","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jocn.2016.10.038","article-title":"Protective effect of nicotinamide adenine dinucleotide (NAD(+)) against spinal cord ischemia-reperfusion injury via reducing oxidative stress-induced neuronal apoptosis","volume":"36","author":"Xie","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0380","doi-asserted-by":"crossref","first-page":"7063874","DOI":"10.1155\/2017\/7063874","article-title":"Nicotinamide adenine dinucleotide protects against spinal cord ischemia reperfusion injury-induced apoptosis by blocking autophagy","volume":"2017","author":"Xie","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2023.114479_bb0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.expneurol.2023.114479_bb0390","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.bbapap.2016.06.014","article-title":"NAD(+) metabolism: bioenergetics, signaling and manipulation for therapy","volume":"1864","author":"Yang","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2023.114479_bb0395","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1021\/jm701001c","article-title":"Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells","volume":"50","author":"Yang","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2023.114479_bb0400","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1074\/jbc.RA118.005772","article-title":"Dihydronicotinamide riboside is a potent NAD(+) concentration enhancer in vitro and in vivo","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114479_bb0405","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jnr.20289","article-title":"NAD+ as a metabolic link between DNA damage and cell death","volume":"79","author":"Ying","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2023.114479_bb0410","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/glia.20176","article-title":"Cell proliferation and replacement following contusive spinal cord injury","volume":"50","author":"Zai","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2023.114479_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/nu14010113","article-title":"Synthesis, stability, and bioavailability of nicotinamide riboside trioleate chloride","volume":"14","author":"Zarei","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.expneurol.2023.114479_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312934","article-title":"The MAPK signaling pathway presents novel molecular targets for therapeutic intervention after traumatic spinal cord injury: a comparative cross-species transcriptional analysis","volume":"22","author":"Zavvarian","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2023.114479_bb0425","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.aaf2693","article-title":"NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice","volume":"352","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2023.114479_bb0430","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/brain\/awv002","article-title":"Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment","volume":"138","author":"Zhou","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2023.114479_bb0435","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7150\/ijbs.38487","article-title":"Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activation of mitochondrial unfolded protein response signaling in the brain of ALS SOD1(G93A) mice","volume":"16","author":"Zhou","year":"2020","journal-title":"Int. J. Biol. Sci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:58:11Z","timestamp":1762149491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488623001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":87,"alternative-id":["S0014488623001644"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114479","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.17.524307","asserted-by":"object"}]},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevation of NAD+ by nicotinamide riboside spares spinal cord tissue from injury and promotes locomotor recovery","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114479"}}